跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Allase - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Allase
Approved
STANDARD
Allase
Interphil Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5fcdb5b21a7fb9ec
Company
Interphil Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
5fcdb5b21a7fb9ec
Drug Approval Philippines Name
Allase
Product Name
Allase
Registration Number
DRP-1209
Brand Name
Allase
Generic Name
Glibenclamide
Dosage Form
Tablet
Dosage Strength
5 mg
Manufacturer
Interphil Laboratories, Inc.
Issuance Date
27 July 2023
Expiry Date
09 January 2029
Pharmacologic Category
Oral Hypoglycemic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5fcdb5b21a7fb9ec
Type
Standard
Back to Philippines FDA Approvals